Healthways Inc. (NASDAQ:HWAY)’s share price traded up 4.1% during mid-day trading on Friday . The stock traded as high as $16.60 and last traded at $16.59, with a volume of 519,951 shares trading hands. The stock had previously closed at $15.93.

A number of equities analysts have weighed in on HWAY shares. Zacks Investment Research raised Healthways from a “sell” rating to a “hold” rating in a research report on Tuesday, May 3rd. Jefferies Group reaffirmed a “hold” rating and set a $13.00 price target on shares of Healthways in a research report on Tuesday, May 3rd. Barrington Research reaffirmed a “buy” rating on shares of Healthways in a research report on Saturday, April 30th. Finally, FBR & Co reaffirmed a “buy” rating on shares of Healthways in a research report on Friday, April 29th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. Healthways has a consensus rating of “Hold” and an average price target of $13.40.

The firm has a 50-day moving average price of $12.10 and a 200-day moving average price of $11.52. The stock’s market capitalization is $608.60 million.

Healthways (NASDAQ:HWAY) last issued its quarterly earnings data on Thursday, April 28th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.02) by $0.06. During the same period last year, the business earned ($0.05) EPS. The firm earned $189.20 million during the quarter, compared to the consensus estimate of $185.68 million. Healthways’s revenue was down .4% compared to the same quarter last year. On average, analysts expect that Healthways Inc. will post $0.24 earnings per share for the current year.

Several institutional investors recently modified their holdings of HWAY. American Capital Management Inc. increased its position in shares of Healthways by 4.0% in the fourth quarter. American Capital Management Inc. now owns 896,380 shares of the company’s stock worth $11,536,000 after buying an additional 34,590 shares during the period. Royce & Associates LLC increased its stake in shares of Healthways by 25.2% in the fourth quarter. Royce & Associates LLC now owns 796,704 shares of the company’s stock worth $10,254,000 after buying an additional 160,500 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its stake in shares of Healthways by 37.1% in the fourth quarter. BNP Paribas Arbitrage SA now owns 80,127 shares of the company’s stock worth $1,031,000 after buying an additional 21,702 shares during the last quarter.

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.